Back to Newsroom

Auris Medical Announces Transfer to Nasdaq Capital Market

Zug, Switzerland, September 28, 2017 – Auris Medical Holding AG (the “Company”, NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced today the approval of the Company’s request to Nasdaq Stock Market LLC (“Nasdaq”) to transfer the listing of its common shares to the Nasdaq Capital Market from the Nasdaq Global Market. The Company’s shares will continue to trade uninterrupted under the symbol “EARS.”
READ MORE…